Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease.
Herfarth
H
H
Tjaden
C
C
Lukas
M
M
Obermeier
F
F
Dilger
K
K
Müller
R
R
Schölmerich
J
J
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001379:Azathioprine / Q000009:adverse effects*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D019804:Mesalamine / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D019804:Mesalamine; D001379:Azathioprine